Medical devices, healthcare technology and the business of care
510(k) clearance · K262646

Calibrate MAX System; Calibrate NanoTec MAX System; Calibrate CCX Interbody System; Calibrate NanoTec CCX Interbody System

Alphatec Spine, Inc. · Decision date Oct 21, 2026

MEDTECHLEDGER EXPLANATIONK262646

What did the FDA decide?

On October 21, 2026, the FDA recorded a substantially equivalent (SESE) decision for K262646, a traditional 510(k) submitted by Alphatec Spine, Inc. of Carlsbad, California, and received July 30, 2026. The submission covers the Calibrate MAX System, Calibrate NanoTec MAX System, Calibrate CCX Interbody System and Calibrate NanoTec CCX Interbody System, classified under 21 CFR 888.3080 as an intervertebral body fusion device with bone graft, lumbar, Class II, product codes MAX and MQP. SESE denotes clearance, not premarket approval.

The summary describes expandable lumbar interbody fusion implants inserted via posterior or transforaminal approaches, made from titanium alloy, PEEK and cobalt chrome, with anti-migration teeth and grit-blasted endplate surfaces; the NanoTec variants add a 20–40 nanometer hydroxyapatite surface treatment. The primary predicate listed is K243461 (Calibrate Interbody Systems, cleared March 4, 2025), with additional predicates including K173025, K232173, K080699, K241375, K242147 and K033109. The source does not include the FDA's decision rationale or any clinical performance data.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 21, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262646
Regulatory pathway
510(k) premarket notification
Product code
MAX
Decision code
SESE
Decision date
Oct 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intervertebral Fusion Device With Bone Graft, Lumbar.

Product code
MAX
FDA device class
2

FDA decision timeline

  1. K262646 received

    Application receipt date recorded by FDA.

  2. K262646 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MAX

Product / regulatory recordCompanyPathwayDecision dateSource
Solco Biomedical Company India Private Limited510(k) clearanceNov 6, 2026FDA
MEDTRONIC SOFAMOR DANEK USA, INC.510(k) clearanceOct 29, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Alphatec Spine, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Carlsbad, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records